Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 33% ± 11% | |
peripheral blood | 18 studies | 35% ± 12% | |
intestine | 10 studies | 27% ± 10% | |
brain | 10 studies | 31% ± 13% | |
kidney | 7 studies | 27% ± 7% | |
liver | 7 studies | 36% ± 18% | |
eye | 5 studies | 29% ± 9% | |
lymph node | 5 studies | 28% ± 5% | |
pancreas | 4 studies | 46% ± 22% | |
bone marrow | 4 studies | 41% ± 15% | |
uterus | 4 studies | 43% ± 19% | |
breast | 4 studies | 32% ± 11% | |
prostate | 4 studies | 30% ± 11% | |
adipose | 4 studies | 32% ± 11% | |
placenta | 3 studies | 49% ± 13% | |
heart | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14252.75 | 1444 / 1445 | 100% | 156.55 | 183 / 183 |
lung | 100% | 12383.54 | 577 / 578 | 100% | 121.77 | 1153 / 1155 |
stomach | 100% | 13405.95 | 359 / 359 | 100% | 130.65 | 285 / 286 |
intestine | 100% | 14472.69 | 966 / 966 | 99% | 132.82 | 524 / 527 |
breast | 100% | 14340.19 | 459 / 459 | 99% | 144.99 | 1107 / 1118 |
pancreas | 100% | 15523.86 | 328 / 328 | 99% | 107.94 | 176 / 178 |
ovary | 100% | 12768.07 | 180 / 180 | 99% | 73.70 | 425 / 430 |
prostate | 100% | 10183.00 | 244 / 245 | 99% | 141.97 | 497 / 502 |
thymus | 100% | 11643.14 | 653 / 653 | 98% | 122.25 | 595 / 605 |
bladder | 100% | 14557.67 | 21 / 21 | 98% | 105.13 | 495 / 504 |
skin | 100% | 22537.30 | 1809 / 1809 | 98% | 156.36 | 462 / 472 |
brain | 99% | 6820.52 | 2606 / 2642 | 99% | 97.69 | 696 / 705 |
uterus | 100% | 13867.48 | 170 / 170 | 97% | 114.45 | 445 / 459 |
kidney | 100% | 6972.84 | 89 / 89 | 95% | 87.27 | 854 / 901 |
adrenal gland | 100% | 12158.73 | 258 / 258 | 89% | 75.23 | 204 / 230 |
liver | 97% | 6093.35 | 219 / 226 | 91% | 69.54 | 369 / 406 |
adipose | 100% | 15678.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13918.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 27208.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9746.89 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.39 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 127.82 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 138.78 | 77 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 123.73 | 43 / 45 |
heart | 93% | 9013.45 | 798 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 8588.56 | 655 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0075525 | Biological process | viral translational termination-reinitiation |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0006413 | Biological process | translational initiation |
GO_0002188 | Biological process | translation reinitiation |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0075522 | Biological process | IRES-dependent viral translational initiation |
GO_0005730 | Cellular component | nucleolus |
GO_0043614 | Cellular component | multi-eIF complex |
GO_0005874 | Cellular component | microtubule |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071541 | Cellular component | eukaryotic translation initiation factor 3 complex, eIF3m |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0005829 | Cellular component | cytosol |
GO_0071540 | Cellular component | eukaryotic translation initiation factor 3 complex, eIF3e |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | EIF3A |
Protein name | Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185) Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) eIF3A protein |
Synonyms | EIF3S10 KIAA0139 eIF3a |
Description | FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis . The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation . The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression . .; FUNCTION: (Microbial infection) Essential for the initiation of translation on type-1 viral ribosomal entry sites (IRESs), like for HCV, PV, EV71 or BEV translation . .; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 . . FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . |
Accessions | Q7Z5T5 J9R021 Q3B770 Q6ZNE1 Q6P1R0 ENST00000369144.8 [Q14152-1] Q24JU4 Q14152 Q05BS0 |